Melatonin: Receptor-mediated events that may affect breast and other steroid hormone-dependent cancers

Molecular Carcinogenesis

Volumn 21, Issue 3, 1998, Pages 149-155

  Baldwin, William S ^a   Barrett, J Carl ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Electromagnetic fields; Estrogen; Light at night; Proliferation

Indexed keywords

ESTROGEN; MELATONIN;

B LYMPHOCYTE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER RISK; ELECTROMAGNETIC FIELD; HOMEOSTASIS; HORMONE BLOOD LEVEL; HORMONE DEPENDENCE; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOREGULATION; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; RECEPTOR AFFINITY; REVIEW;

BREAST NEOPLASMS; ELECTROMAGNETIC FIELDS; HUMANS; MELATONIN; NEOPLASMS, HORMONE-DEPENDENT; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, MELATONIN;

EID: 0031968571     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199803)21:3<149::AID-MC1>3.0.CO;2-H     Document Type: Review

References (46)

1. Savitz D, Calle E. Leukemia and occupational exposure to electromagnetic fields: Review of epidemiological surveys. J Occup Med 29:47-51, 1987.
2. Coleman M, Beral V. A review of epidermiological studies of the health effects of living or working with electricity generation and transmission equipment. Int J Epidemiol 17:1-13, 1988.
3. Theriault G, Goldberg M, Miller AB, et al. Cancer risks associated with occupational exposure to magnetic fields among electric utility workers in Ontario and Quebec, Canada and France: 1970-1989. Am J Epidemiol 139:550-572, 1994.
4. Loomis DP, Savitz DA, Ananth CV. Breast cancer mortality among electrical workers in the United States. J Natl Cancer Inst 86:921-925, 1994.
5. Tricholopoulos D. Are electric or magnetic fields affecting mortality from breast cancer in women? J Natl Cancer Inst 86:885-886, 1994.
6. Taubes G. Breast cancer link claimed, criticized. Science 264:1658, 1994.
7. Stevens RG, Davis S, Thomas DR, Anderson LE, Wilson BW. Electric power, pineal function, and the risk of breast cancer. FASEB J 6:853-860, 1992.
8. Stevens RG, Davis S. The melatonin hypothesis: Electric power and breast cancer. Environ Health Perspect 104:135-140, 1996.
9. Reppert SM, Weaver DR. Melatonin madness. Cell 83:1059-1062, 1995.
10. 125I]iodomelatonin binding sites in spleens of birds and mammals. Neurosci Lett 125:175-178, 1991.
11. Kennaway DJ, Hugel JM. Melatonin binding sites: Are they receptors? Mol Cell Endocrinol 88:C1-C9, 1992.
12. Vanecek J, Pavlik A, Illnerova H. Hypothalamic melatonin receptor sites revealed by autoradiography. Brain Res 435:359-362, 1987.
13. Weaver DR, Rivkees SA, Reppert SM. Localization and characterization of melatonin receptors in rodent brain by in vitro autoradiography. J Neurosci 9:2581-2590, 1989.
14. Weaver DR, Namboodiri MA, Reppert SM. Iodinated melatonin mimics melatonin action and reveals discrete binding sites in fetal brain. FEBS Lett 228:123-127, 1988.
15. Vanecek J, Klein DC. Mechanism of melatonin signal transduction in the neonatal rat pituitary. Neurochem Int 27:273-278, 1995.
16. Oaknin-Bendahan S, Anis Y, Nir I, Zisapel N. Pinealectomy but not melatonin supplementation affects the diurnal variations in 125I-melatonin binding sites in the rat brain. J Basic Clin Physiol Pharmacol 3:253-268, 1992.
17. Glass J, Lynch GR. Diurnal rhythm of response to chronic intrahypothalamic melatonin injections in the white-footed mouse, Peromyscus leucopus. Neuroendocrinology 35:117-122, 1982.
18. Maywood ES, Hastings MH. Lesions of the iodomelatonin-binding sites of the mediobasal hypothalamus spare the lactotropic, but block the gonadotropic response of male syrian hamsters to short photoperiod and to melatonin. Endocrinology 136:144-153, 1995.
19. Lincoln GA, Clarke IJ. Photoperiodically-induced cycles in the secretion of prolactin in hypothalamo-pituitary disconnected rams: Evidence for translation of the melatonin signal in the pituitary gland. J Neuroendocrinol 6:251-260, 1994.
20. Carlberg C, Wiesenberg I. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: An unexpected relationship. J Pineal Res 18:171-178, 1995.
21. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 269:28531-28534, 1994.
22. Steinhilber D, Brungs M, Werz O, et al. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 270:7037-7040, 1995.
23. Hill SM, Spriggs LL, Simon MA, Hitoyuki M, Blask DE. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 64:249-256, 1992.
24. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 13:1177-1185, 1994.
25. Sugden D, Rowe SJ. Protein kinase C activation antagonizes melatonin-induced pigment aggregation in Xenopus laevis melanophores. J Cell Biol 119:1515-1521, 1992.
26. 1b melatonin receptor. Proc Natl Acad Sci USA 92:8734-8738, 1995.
27. Acuna-Castroviejo D, Reiter RJ, Menendez-Pelaez A, Pablos MI, Burgos A. Characterization of high-affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res 16:100-112, 1994.
28. Wiesenberg I, Missbach M, Kahlen J-P, Schrader M, Carlberg C. Transcriptional activation of the nuclear receptor RZRα by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res 23:327-333, 1995.
29. Lynch JJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science 187:169-171, 1975.
30. Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: Role in puberty control. Ann N Y Acad Sci 453:205-214, 1985.
31. Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1:362-365, 1984.
32. Kato M, Honma K, Shigemitsu T, Shiga Y. Effects of exposure to a circularly polarized 50-Hz magnetic field on plasma and pineal melatonin levels in rats. Bioelectromagnetics 14:97-106, 1993.
33. Brainard GC, Lewy AJ, Menaker M, et al. Dose-response relationship between light irradiance and the suppression of plasma melatonin in human volunteers. Brain Res 454:212-218, 1988.
34. Brainard GC, Richardson BA, Hurlbut EC, Steinlechner S, Matthews SA, Reiter RJ. The influence of various irradiances of artificial light, twilight, and moonlight on the suppression of pineal melatonin content in the Syrian hamster. J Pineal Res 1:105-119, 1984.
35. Maestroni GJ. The immunoneuroendocrine role of melatonin. J Pineal Res 14:1-10, 1993.
36. Roberts JE. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J Photochem Photobiol B 29:3-15, 1995.
37. Avis IM, Jett M, Boule T, et al. Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling. J Clin Invest 97:806-813, 1996.
38. Abou-el-Ela SH, Prasse KW, Farrell RL, Carroll RW, Wade AE, Bunce OR. Effects of D,L-2-difluoromethylornithine and indomethacin on mammary tumor promotion in rats fed high N-3 and/or N-6 fat diets. Cancer Res 49:1434-1440, 1989.
39. Molis TM, Spriggs LL, Hill SM. Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. International Journal of Oncology 3:687-694, 1993.
40. Molis TM, Spriggs LL, Hill SM. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. Mol Endocrinol 8:1681-1690, 1994.
41. L'Hermite-Baleriaux M, de Launoit Y. Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation? In Vitro Cell Dev Biol Anim 28A:583-584, 1992.
42. Ying SW, Niles LP, Crocker C. Human malignant melanoma cells express high-affinity receptors for melatonin: Antiproliferative effects of melatonin and 6-choromelatonin. Eur J Pharmacol 246:89-96, 1993.
43. Rasmussen DD. Diurnal modulation of rat hypothalamic gonadotropin-releasing hormone release by melatonin in vitro. J Endocrinol Invest 16:1-7, 1993.
44. Vanecek J. Cellular mechanism of melatonin action in neonatal rat pituitary. Neuroendocrinology 61:27-30, 1995.
45. Lawson NO, Wee BE, Blask DE, Castles CG, Spriggs LL, Hill SM. Melatonin decreases estrogen receptor expression in the medial preoptic area of inbred (LSH/SsLak) golden hamsters. Biol Reprod 47:1082-1090, 1992.
46. Blask DE, Pelletier DB, Hill SM, et al. Pineal melatonin inhibition of tumor promotion in the N-nitroso-N-methylurea model of mammary carcinogenesis: Potential involvement of antiestrogenic mechanisms in vivo. J Cancer Res Clin Oncol 117:526-532, 1991.